Church & Dwight Co. competitors

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Albert Bourla (Greek: Άλμπερτ Μπουρλά, born) is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

Anthony J. Allott has been one of our Directors since June 2006 and has been our Chief Executive Officer since March 2006 and our President since August 2004. Mr. Allott was also our Chief Operating Officer from May 2005 until March 2006. From May 2002 until August 2004, Mr. Allott was our Executive Vice President and Chief Financial Officer. Prior to joining us, Mr. Allott was Senior Vice President and Chief Financial Officer of Applied Extrusion Technologies, Inc., or AET, a manufacturer of flexible packaging, since July 1996. From July 1994 until July 1996, Mr. Allott was Vice President and Treasurer of AET. From 1992 until July 1994, Mr. Allott was Corporate Controller and Director of Financial Reporting of Ground Round Restaurants. Prior to that, Mr. Allott was a certified public accountant with Deloitte & Touche LLP.

Linda J. Rendle has served as chief executive officer and director of The Clorox Company since September 2020. During nearly 20 years with the company, she has held numerous senior leadership roles. Previously, she served as president from May 2020 to September 2020. Before becoming president, she served as executive vice president - Cleaning, International, Strategy and Operations from July 2019 to May 2020, and executive vice president - Strategy and Operations from January 2019 to July 2019. Prior to that, she was executive vice president and general manager - Cleaning and Strategy from June 2018 to January 2019, and she served as senior vice president and general manager - Cleaning, from August 2016 to June 2018, with additional responsibility for Professional Products as of April 2017. She served as vice president and general manager - Home Care from October 2014 to August 2016. She began her Clorox career in 2003 in the Sales division, where she served in various positions of increasing responsibility in sales planning and supply chain, culminating in her role as vice president - Sales - Cleaning, from 2012 to 2014. Before joining Clorox, she worked for Procter & Gamble, where she held several positions in sales management. Ms. Rendle holds a bachelor’s degree in economics from Harvard University.

Paresh Chari is a President, Chief Executive Officer, Director at Dura-Line and Chairman/Interim CEO at 4M Carbon Fiber Corp. He has worked as Pres:USA & Fluent Systems Datacom at Mexichem, Board Member at 4M Carbon Fiber Corp, and Pres:Fluent Business Group at Mexichem. Paresh works or has worked at Ameritech College and EMERSON ELECTRIC CO. He attended University of Michigan, National Institute of Technology India, and Indian Institute of Technology Bombay (IIT).